AnaptysBio Inc - Company Profile
Powered by 
All the data and insights you need on AnaptysBio Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date AnaptysBio Inc Strategy Report
- Understand AnaptysBio Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on AnaptysBio Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| WO2022087441A3 | Application | B AND T LYMPHOCYTE ATTENUATOR (BTLA) MODULATORS AND METHOD OF USING SAME | A61K2039/505; A61K2039/545; A61P37/06; C07K16/2818; C07K2317/33; C07K2317/34; C07K2317/75; C07K2317/76; C07K2317/92 | August 25, 2022 |
| US20220235132A1 | Application | PD-1 AGONIST AND METHOD OF USING SAME | A61P37/06; C07K16/2818; C07K2317/52; C07K2317/565 | July 28, 2022 |
| WO2022150642A1 | Application | ANTI-INTERLEUKIN 36 RECEPTOR (IL-36R) THERAPY FOR HIDRADENITIS SUPPURATIVA | A61K2039/505; A61K45/00; A61P17/00 | July 14, 2022 |
| WO2022150644A1 | Application | ANTI-INTERLEUKIN 36 RECEPTOR (IL-36R) THERAPY FOR ACNE | A61P17/10; C07K16/2866 | July 14, 2022 |
| NZ722445A | Application | Antibodies directed against interleukin-33 (il-33) | A61K2039/505; A61K39/3955; A61P1/04; A61P11/00; A61P11/06; A61P17/00; A61P17/06; A61P19/02; A61P29/00; A61P35/00; A61P35/02; A61P37/00; A61P37/02; A61P37/06; A61P37/08; C07K16/244; C07K2317/56; C07K2317/565; C07K2317/76; C07K2317/92 | July 01, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer